Chemiesynth Board Meeting on Aug 12 to Approve Q1 FY27 Unaudited Results

Chemiesynth (Vapi) Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda items include the consideration and approval of the Standalone Unaudited Financial Results for the quarter ended June 30, 2026, along with the limited review report. The board will also discuss and approve the Directors' Report, Management Discussion and Analysis, and other disclosures. Additionally, proposals for increasing the authorized share capital, amending the Memorandum and Articles of Association, and issuing Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis will be considered. The meeting will also finalize arrangements for the 40th Annual General Meeting, including fixing the date, time, venue, and closure of the share transfer book, as well as appointing a scrutinizer and fixing cut-off dates for remote e-voting. The trading window will remain closed until 48 hours after the declaration of results.